Susan Kelly

Selling the assets to Italy’s GVS should help Haemonetics improve its revenue growth and profit margins, analysts said.

U.S. approval of an expanded indication for transcatheter aortic valve replacement in patients without symptoms is among the growth catalysts Edwards outlined in an investor day presentation.

The job cuts in Memphis are part of a turnaround plan that has seen the U.K.-based medical device maker shutter four smaller orthopedics facilities outside the U.S.

Kelly’s departure “does not instill confidence” but shouldn’t affect the robot developer’s timeline for a regulatory submission, said BTIG analyst Ryan Zimmerman.

Under new leadership, the patient monitoring company is allocating resources to fewer projects as it focuses on market opportunities that address unmet needs, a spokesperson said.

The startup’s third round of financing includes support from Intuitive Surgical’s venture capital arm.

MedTech industry news

Pulsed field ablation could soon be used in the majority of electrophysiology procedures to treat atrial fibrillation as Medtronic, Boston Scientific and Johnson & Johnson battle for market share.

Joseph Wright’s resignation is effective in January, and CEO and founder Fred Lampropoulos has been reappointed president.

IPOs in medtech have been sparse, but some analysts said improving market conditions could support a revival of offerings in 2025.